A Randomized, Blinded, Placebo and Standard of Care Controlled Efficacy, Safety, and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2017
Price : $35 *
At a glance
- Drugs Gentamicin/vancomycin (Primary)
- Indications Bacterial infections; Postoperative infections
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 11 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jan 2015 Planned End Date changed from 1 Jan 2015 to 1 Feb 2015 as reported by ClinicalTrials.gov.
- 21 Jan 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.